ROCHESTER, N.Y., Feb. 15, 2017 /PRNewswire/ -- Patient identification Platform (Patient iP) today announced that Rochester Colon & Rectal Surgeons, P.C. is live on the company's advanced analytics platform and enjoying newfound insight into its patient population.
Rochester Colon & Rectal Surgeons, P.C., (RCRS), is a group of surgical specialists committed to caring for people with problems of the intestinal tract. All surgeons are fellowship trained and board certified in colon and rectal surgery and hold expertise in advanced surgical techniques, including J-pouch surgery for ulcerative colitis. Additionally, RCRS providers are in the top 1% of all surgeons performing robotic colorectal surgery.
RCRS engaged with Patient iP through the company's relationship with MEDENT, a software development and services company focused on automating medical practices; RCRS is a longtime customer of MEDENT for its practice management and electronic medical records offerings.
The Patient iP solution, recognized in 2016 by Microsoft Corporation as a Health Innovation Award Winner, improves the historically manual and time-intensive process of site selection and patient matching for clinical trial participation. Under the partnership, MEDENT medical practice customer data is being processed through Patient iP's analytics engine to identify individuals across MEDENT customer sites that are matches for clinical trial opportunities. Beyond that opportunity for delivering enhanced patient care, the combination of Patient iP with MEDENT delivers unique reporting capabilities around population health initiatives, which is of great interest to RCRS given the surgical capabilities its provider team possesses.
According to Practice Administrator Kristin Coon, "The implementation of Patient iP was fast and required very little from our end in terms of resources. We now are able to view our patient data in an advanced analytical lens. Our team looks at patient outcomes, trends and opportunities for improvement in new ways. Not only does the solution help our providers with greater insight into patient status post encounter, but it also sets us up for clinical research participation which would be new for RCRS."
"Earlier this month a new study from the Tufts Center for the Study of Drug Development found that nearly all physicians (91%), and the majority of nurses (72%) feel comfortable discussing the opportunity to participate in a clinical trial with patients, but physicians refer less than 0.2% of their patients into clinical trials, and nurses refer even fewer. This is precisely the challenge that Patient iP is looking to solve. Today virtually all health data is stored electronically but rarely leveraged in a timely, efficacious manner to help patients seeking treatment alternatives," said Michael Margiotta, founder and CEO of Patient identification Platform.
For MEDENT customers interested in taking a look at Patient iP, please contact the company at its corporate web site: http://www.patientip.com/medent/. For other EMR providers interested in how to offer the Patient iP platform as an integrated offering, senior leaders from Patient iP will be at HIMSS and would enjoy the opportunity to meet.
About Patient identification Platform
The patented Patient iP solution bridges many of the most significant and costly gaps encountered when sponsors and contract research organizations conduct clinical trials: timely patient identification and enrollment. Adoption of the Platform enables CROs to streamline operations, helps study sites leverage existing electronic patient health data, and provides life sciences organizations with the speed necessary to achieve first-mover status. Since Patient iP's unique technology allows for faster development and approval of drugs and therapies, patients too are benefactors of the solution's range of benefits given the potential for healthier and longer lives. For more information, visit us at www.patientip.com or follow us on Twitter @PatientIP.
About MEDENT
MEDENT is a software development and services company focused on automating medical practices. We offer an All-In-One EMR/EHR, Patient Portal & Practice Management system providing a high-level of interoperability and automation. A recent Medical Economics survey ranked MEDENT EHR the #1 EHR system in the nation for the second year in a row. The MEDENT system is available in the cloud as a service or as a server based system in the medical practice. For more information, visit www.medent.com.
Patient iP Contact: Jen Crowley, [email protected]
This content was issued through the press release distribution service at Newswire.com. For more info visit: http://www.newswire.com
Advertisement
Rochester Colon & Rectal Surgeons, P.C., (RCRS), is a group of surgical specialists committed to caring for people with problems of the intestinal tract. All surgeons are fellowship trained and board certified in colon and rectal surgery and hold expertise in advanced surgical techniques, including J-pouch surgery for ulcerative colitis. Additionally, RCRS providers are in the top 1% of all surgeons performing robotic colorectal surgery.
Advertisement
RCRS engaged with Patient iP through the company's relationship with MEDENT, a software development and services company focused on automating medical practices; RCRS is a longtime customer of MEDENT for its practice management and electronic medical records offerings.
The Patient iP solution, recognized in 2016 by Microsoft Corporation as a Health Innovation Award Winner, improves the historically manual and time-intensive process of site selection and patient matching for clinical trial participation. Under the partnership, MEDENT medical practice customer data is being processed through Patient iP's analytics engine to identify individuals across MEDENT customer sites that are matches for clinical trial opportunities. Beyond that opportunity for delivering enhanced patient care, the combination of Patient iP with MEDENT delivers unique reporting capabilities around population health initiatives, which is of great interest to RCRS given the surgical capabilities its provider team possesses.
According to Practice Administrator Kristin Coon, "The implementation of Patient iP was fast and required very little from our end in terms of resources. We now are able to view our patient data in an advanced analytical lens. Our team looks at patient outcomes, trends and opportunities for improvement in new ways. Not only does the solution help our providers with greater insight into patient status post encounter, but it also sets us up for clinical research participation which would be new for RCRS."
"Earlier this month a new study from the Tufts Center for the Study of Drug Development found that nearly all physicians (91%), and the majority of nurses (72%) feel comfortable discussing the opportunity to participate in a clinical trial with patients, but physicians refer less than 0.2% of their patients into clinical trials, and nurses refer even fewer. This is precisely the challenge that Patient iP is looking to solve. Today virtually all health data is stored electronically but rarely leveraged in a timely, efficacious manner to help patients seeking treatment alternatives," said Michael Margiotta, founder and CEO of Patient identification Platform.
For MEDENT customers interested in taking a look at Patient iP, please contact the company at its corporate web site: http://www.patientip.com/medent/. For other EMR providers interested in how to offer the Patient iP platform as an integrated offering, senior leaders from Patient iP will be at HIMSS and would enjoy the opportunity to meet.
About Patient identification Platform
The patented Patient iP solution bridges many of the most significant and costly gaps encountered when sponsors and contract research organizations conduct clinical trials: timely patient identification and enrollment. Adoption of the Platform enables CROs to streamline operations, helps study sites leverage existing electronic patient health data, and provides life sciences organizations with the speed necessary to achieve first-mover status. Since Patient iP's unique technology allows for faster development and approval of drugs and therapies, patients too are benefactors of the solution's range of benefits given the potential for healthier and longer lives. For more information, visit us at www.patientip.com or follow us on Twitter @PatientIP.
About MEDENT
MEDENT is a software development and services company focused on automating medical practices. We offer an All-In-One EMR/EHR, Patient Portal & Practice Management system providing a high-level of interoperability and automation. A recent Medical Economics survey ranked MEDENT EHR the #1 EHR system in the nation for the second year in a row. The MEDENT system is available in the cloud as a service or as a server based system in the medical practice. For more information, visit www.medent.com.
Patient iP Contact: Jen Crowley, [email protected]
This content was issued through the press release distribution service at Newswire.com. For more info visit: http://www.newswire.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/rochester-colon--rectal-surgeons-adopts-patient-identification-platform-for-advanced-analytical-capabilities-300407759.html
SOURCE Patient identification Platform
